These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18166325)

  • 1. Evaluation of physiological alterations of the placenta through analysis of cell-free messenger ribonucleic acid concentrations of angiogenic factors.
    Purwosunu Y; Sekizawa A; Farina A; Wibowo N; Koide K; Okazaki S; Nakamura M; Okai T
    Am J Obstet Gynecol; 2008 Jan; 198(1):124.e1-7. PubMed ID: 18166325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award.
    Chaiworapongsa T; Romero R; Espinoza J; Bujold E; Mee Kim Y; Gonçalves LF; Gomez R; Edwin S
    Am J Obstet Gynecol; 2004 Jun; 190(6):1541-7; discussion 1547-50. PubMed ID: 15284729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia.
    Chaiworapongsa T; Romero R; Kim YM; Kim GJ; Kim MR; Espinoza J; Bujold E; Gonçalves L; Gomez R; Edwin S; Mazor M
    J Matern Fetal Neonatal Med; 2005 Jan; 17(1):3-18. PubMed ID: 15804781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma markers of angiogenesis in pregnancy induced hypertension.
    Nadar SK; Karalis I; Al Yemeni E; Blann AD; Lip GY
    Thromb Haemost; 2005 Nov; 94(5):1071-6. PubMed ID: 16363251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placenta-derived, cellular messenger RNA expression in the maternal blood of preeclamptic women.
    Okazaki S; Sekizawa A; Purwosunu Y; Farina A; Wibowo N; Okai T
    Obstet Gynecol; 2007 Nov; 110(5):1130-6. PubMed ID: 17978129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop.
    McKeeman GC; Ardill JE; Caldwell CM; Hunter AJ; McClure N
    Am J Obstet Gynecol; 2004 Oct; 191(4):1240-6. PubMed ID: 15507947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-free mRNA concentrations of CRH, PLAC1, and selectin-P are increased in the plasma of pregnant women with preeclampsia.
    Purwosunu Y; Sekizawa A; Farina A; Wibowo N; Okazaki S; Nakamura M; Samura O; Fujito N; Okai T
    Prenat Diagn; 2007 Aug; 27(8):772-7. PubMed ID: 17554801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble and membranous vascular endothelial growth factor receptor-1 in pregnancies complicated by pre-eclampsia.
    Tripathi R; Rath G; Jain A; Salhan S
    Ann Anat; 2008 Nov; 190(5):477-89. PubMed ID: 18992679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationship to peripheral vascular resistance.
    Bosio PM; Wheeler T; Anthony F; Conroy R; O'herlihy C; McKenna P
    Am J Obstet Gynecol; 2001 Jan; 184(2):146-52. PubMed ID: 11174494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression and significance of soluble fms-like tyrosine kinase 1 in preeclampsia placenta].
    Ye YH; Liu L; Zhan Y; Peng W
    Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):521-4. PubMed ID: 17083834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenic factors and pre-eclampsia: an early marker is needed.
    Stepan H
    Clin Sci (Lond); 2009 Feb; 116(3):231-2. PubMed ID: 19032146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative distribution of a panel of circulating mRNA in preeclampsia versus controls.
    Farina A; Sekizawa A; Purwosunu Y; Rizzo N; Banzola I; Concu M; Morano D; Giommi F; Bevini M; Mabrook M; Carinci P; Okai T
    Prenat Diagn; 2006 Dec; 26(12):1115-20. PubMed ID: 16952198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel human-specific soluble vascular endothelial growth factor receptor 1: cell-type-specific splicing and implications to vascular endothelial growth factor homeostasis and preeclampsia.
    Sela S; Itin A; Natanson-Yaron S; Greenfield C; Goldman-Wohl D; Yagel S; Keshet E
    Circ Res; 2008 Jun; 102(12):1566-74. PubMed ID: 18515749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia.
    Verlohren S; Galindo A; Schlembach D; Zeisler H; Herraiz I; Moertl MG; Pape J; Dudenhausen JW; Denk B; Stepan H
    Am J Obstet Gynecol; 2010 Feb; 202(2):161.e1-161.e11. PubMed ID: 19850276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The relativity of vascular endothelium growth factor receptor-1 and preeclampsia].
    Zou CL; Liu XH; Yue BM; Fu JH; He GL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Sep; 37(5):765-8. PubMed ID: 17037747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Predictive value of soluble vascular endothelial growth factor receptor 1 for preeclampsia in second-trimester].
    Chen Q; Zhao Y; Zou L; Wang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2007 Mar; 42(3):161-4. PubMed ID: 17537299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calprotectin plasma level is elevated in preeclampsia.
    Holthe MR; Staff AC; Berge LN; Fagerhol MK; Lyberg T
    Acta Obstet Gynecol Scand; 2005 Feb; 84(2):151-4. PubMed ID: 15683375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences.
    Tsatsaris V; Goffin F; Munaut C; Brichant JF; Pignon MR; Noel A; Schaaps JP; Cabrol D; Frankenne F; Foidart JM
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5555-63. PubMed ID: 14602804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of the level of circulating antiangiogenic factors to the clinical manifestations of preeclampsia.
    Kim YN; Lee DS; Jeong DH; Sung MS; Kim KT
    Prenat Diagn; 2009 May; 29(5):464-70. PubMed ID: 19242927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of preeclampsia by analysis of cell-free messenger RNA in maternal plasma.
    Purwosunu Y; Sekizawa A; Okazaki S; Farina A; Wibowo N; Nakamura M; Rizzo N; Saito H; Okai T
    Am J Obstet Gynecol; 2009 Apr; 200(4):386.e1-7. PubMed ID: 19217595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.